Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1075P is a pseudogene of the U6 small nuclear RNA (snRNA) gene family. While the authentic U6 snRNA is a crucial component of the spliceosome complex, responsible for catalyzing the excision of introns from pre-mRNA during splicing in eukaryotes[1][5], the RNU6-1075P locus represents a non-functional copy (pseudogene) that does not produce a functional RNA or protein product. Pseudogenes like RNU6-1075P are common in vertebrate genomes and are generally considered non-coding genomic elements, typically the result of gene duplication or retrotransposition events followed by mutations that disrupt their function[6][8]. There is no evidence that RNU6-1075P serves as a therapeutic target, nor does it have known disease associations, interacting drugs, or biomarker roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1075, pseudogene (RNU6-1075P).